- What You Need to Know
- Getting Tested
- CDC Vaccine Data Tracker
Vaccine Rollout as of May 27:
Total Distributed: 20,215,485. Total Administered: 16,783,474.VA Vaccine DashboardCDC COVID-19 Vaccines
Visit your state's vaccine dashboard to learn more about their distribution guidelines. The CDC also has updated information on COVID-19 vaccines, including recommendations processes, differences about the different types, their benefits, safety data, and frequently asked questions.Crisis Text Line
- What You Need to Know
The BinaxNOW TM COVID-19 Ag Card is an immunochromatographic membrane assay that uses ... Abbott suggests that you record these controls for each test run. Procedural Controls:
BinaxNOW COVID-19 Ag CARD HOME TEST KIT Getting Started A.Download the NAVICA app from the Apple App Store or Google Play Store on your smartphone or tablet B.Login or create a NAVICA account – create a managed profile for any children or other dependents you plan to get tested under the “Account and Settings” icon at the top of the screen.
Aug 11, 2021 · I've been looking at Abbott BinaxNOW™ COVID-19 Ag Card Home Test with eMed Telehealth Services and as far as I can tell, it would meet the requirements of a self administered antigen test with the eMed Telehealth services. Is a self-test acceptable?
Fisher Scientific - Easy to use 15 min. rapid antigen test for detecting active infections of COVID-19 Shop Abbott BinaxNOW™ COVID-19 Ag Card at Fishersci.com
Jun 03, 2022 · BinaxNOW COVID-19 Ag Card joins our previously launched tests, including high-volume m2000 and Alinity ™ m molecular laboratory systems, ID NOW ™ rapid molecular point-of-care platforms, antibody tests for our high-throughput ARCHITECT ® i1000SR and i2000SR and Alinity i laboratory instruments. All are available in the U.S. through FDA EUAs.
Abbott rapid COVID-19 tests are reliable, affordable, and widely available The BinaxNOW COVID-19 Ag Card and the BinaxNOW COVID-19 Ag Card Home Test have received Emergency Use Authorization by the U.S. Food and Drug Administration. Both tests work with the NAVICA system to provide fast, reliable results that can be displayed in the NAVICA app.
In data submitted to the FDA from a clinical study conducted by Abbott with several leading U.S. research universities, the BinaxNOW COVID-19 Ag Card was compared to an FDA authorized high sensitivity SARS-CoV-2 test and correctly identified 84.6% of positive specimens and 98.5% of negative specimens.